Hope the ‘repurposing’ is purposeful – psoriasis to covid cytokine storm

ALZUMAb, Biocon’s brand of Itolizumab is a joint research product with Cuba. It was officially launched in India in 2013 for Psoriasis, an autoimmune skin disorder with white scales. Being a monoclonal antibody, Itolizumab down regulates the pro-inflammatory cytokines. With this knowledge the Cubans used it on severe Covid patients and got promising outcomes. Biocon is now conducting trials in six hospitals in Mumbai, Delhi and Bengaluru. One more promising contender to fight the ‘Cytokine storm’. We hope this ‘Repurposing’ is purposeful.

Published by BhaskarChak

Internet Entrepreneur, Faculty of Marketing and Digital Entrepreneurship, Pharmaceutical Marketing Veteran, TEDx Speaker, Serious Amateur in Clicking & Writing

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: